Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from MHRA

Michael Gove ‘wanted to circumvent watchdog’ to push through Dyson bid, Covid inquiry told

Suggestion he pressured MHRA to approve ventilators for NHS is ‘ludicrous’, former minister says

The Guardian - UK

Watchdog official ‘said Gove wanted to circumvent process’ for Dyson ventilator

The former minister was giving evidence to UK Covid-19 Inquiry.

Evening Standard

UK scientists develop DNA sequencing system to fight superbugs

Exclusive: Sequencing will help doctors identify bacteria that cause infections and offer effective treatments faster and more accurately

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Urgent Boots paracetamol recall after packets found to contain a different drug

The medicines regulator has put out an urgent notice

The Independent UK

Packaging error leads to recall of commonly-used drug

Certain packs of Boots paracetamol tablets have been recalled.

Evening Standard

MS patients suffer side-effects after NHS England switches to cheaper drug

Scores of people experience complications after change from Tysabri to Tyruko as part of NHS drive to save money

The Guardian - UK

‘It’s not ethical and it’s not medical’: how UK rehab clinics are cashing in on NAD+

They are beloved by A-listers and surging in popularity. But claims that NAD+ infusions are a fix for addiction are unproven, risky – and possibly illegal, an Observer investigation reveals

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Advertising regulator launches nine investigations into weight loss jab ads

Exclusive: ASA calls number of parallel probes ‘significant’ and describes tackling issue as ‘priority’ after it issued warning to advertisers for drugs including Ozempic and Wegovy

The Independent UK

UK online pharmacies face stricter rules for sales of weight-loss jabs

Regulators to tighten up criteria after concerns over inappropriate private prescriptions of popular drugs

The Guardian - UK

Pharmacy leaders issue fresh warning over online sales of weight loss jabs

Pharmacists say they are aware of people being wrongly prescribed the drugs who have previously had eating disorders, or whose body weight is low.

Evening Standard

Reporting of vaccine side-effects should be mandatory – Tory former minister

Esther McVey said there was a ‘gross underreporting’ of unintended impacts of vaccines to the medicines regulator.

The Independent UK

The big menopause swizz: do hormone supplements really work?

The global market for menopause products is worth £16.93bn, the majority of that spent on dietary supplements – but is there any evidence they do anything?

The Guardian - UK

Woman ‘suicidal’ after taking same antidepressants as Thomas Kingston issues warning over side effects

Coroner and MPs raise concerns as almost 200 alerts made in decade to regulator over deaths linked to drugs

The Independent UK

‘Don’t buy weight-loss pills online without prescription after Christmas over-eating,’ Britons warned

The warning was issued by the UK’s medicines watchdog

Evening Standard

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

NHS delays may drive patients to buy unsafe weight-loss drugs, says top GP

People warned against buying illegal weight-loss medicines through beauty salons or fake pharmacy websites

The Guardian - UK

‘Wild west’: experts concerned by illegal promotion of weight-loss jabs in UK

Guardian review finds many online pharmacies flouting strict advertising rules that govern prescription-only drugs

The Guardian - UK

Shrinking waistlines and growing profits: the weight-loss drug boom

Drugs such as Wegovy amd Mounjaro are an attractive prospect for online businesses and traditional pharmacies as well as the firms that make them

The Independent UK

More than 100 alerts over deaths linked to antidepressants taken by Thomas Kingston

The UK’s medicines regulator is reviewing safety alerts for 30 common antidepressants

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

A common nasal decongestant lacks evidence but is still sold in the UK

For years, the drug phenylephrine has been a popular choice for relieving nasal congestion, however, the US Food and Drug Administration (FDA) is considering removing oral phenylephrine medicines from pharmacy shelves. Recent FDA findings suggest it lacks effectiveness.

Evening Standard

Warning of future deaths risk after three babies who had contaminated feed died

Three premature babies received total parenteral nutrition feed, contaminated by Bacillus cereus, while undergoing care in hospital.

Al Jazeera

The UK’s NHS to roll out free antismoking pill. Will it work?

The UK’s National Health Service hopes the drug will help reduce the cost of treating serious illnesses.

The Conversation

Alzheimer’s treatment donanemab is not a ‘miracle drug’ – not providing it on the NHS is the right choice

There was frustration in some corners of the media when it was announced that a new drug to slow the progression of Alzheimer’s was not going to be made available on the NHS.

The Conversation

Alzheimer’s drug approved in the UK, but it won’t be available on the NHS – here’s why

The UK’s drugs regulator – the MHRA – has approved the Alzheimer’s drug donanemab, but it won’t be available on the NHS.

Evening Standard

Doctors urged to look out for weight loss jab ‘misuse’

The medicines regulator has also urged medics to warn patients of side effects.

The Guardian - UK

Tens of thousands of UK dementia patients to be enrolled in clinical trials

News of the £20m scheme comes as new drug for Alzheimer’s was rejected for use on NHS in England

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.